Literature DB >> 1604811

Syncytium formation is induced in the murine neuroblastoma cell cultures which produce pathogenic type G proteins of the rabies virus.

K Morimoto1, Y J Ni, A Kawai.   

Abstract

We investigated comparatively the interactions of host cells with two types of rabies virus G protein, an avirulent type G (Gln) and a virulent type G (Arg) protein, having glutamine and arginine at position 333, respectively. For this purpose, we established four types of cell lines (referred to as G(Gln)-NA, G(Arg)-NA, G(Gln)-BHK, and G(Arg)-BHK cells, respectively) by transfecting either the G(Gln)-cDNA or G(Arg)-cDNA into two kinds of cells, murine neuroblastoma C1300 (clone NA) and nonneuronal BHK-21. Both G(Gln)-NA and G(Arg)-NA cells produced G proteins when they were treated with 5 mM sodium butyrate, but only G(Arg)-NA cells formed syncytia at the neutral pH, which was suppressed by anti-G antiserum. The sodium butyrate-treated G(Arg)-NA cells fused also with sodium butyrate-treated NA cells under coculture conditions, but neither with untreated NA cells nor with BHK-21 cells. On the other hand, both G(Gln)-BHK and G(Arg)-BHK cells constitutively produced G proteins, but no syncytium was produced at the neutral pH. G(Arg)-BHK cells, however, formed syncytia with the sodium butyrate-treated NA cells when they were cocultured. These results suggest that only G(Arg) has a potential ability to produce syncytia of NA cells regardless of cell types by which G(Arg) protein was produced and also suggest that a certain cellular factor(s) is required for the syncytium formation, the factor(s) which is lacking in BHK-21 and untreated NA cells but is produced by the sodium butyrate-treated NA cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1604811      PMCID: PMC7130052          DOI: 10.1016/0042-6822(92)90696-m

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  41 in total

1.  Comparison of rabies virus G proteins produced by cDNA-transfected animal cells that display either inducible or constitutive expression of the gene.

Authors:  K Morimoto; A Kawai; K Mifune
Journal:  J Gen Virol       Date:  1992-02       Impact factor: 3.891

2.  Sequence determination of the Sendai virus fusion protein gene.

Authors:  B M Blumberg; C Giorgi; K Rose; D Kolakofsky
Journal:  J Gen Virol       Date:  1985-02       Impact factor: 3.891

3.  Membrane fusion activity, oligomerization, and assembly of the rabies virus glycoprotein.

Authors:  M A Whitt; L Buonocore; C Prehaud; J K Rose
Journal:  Virology       Date:  1991-12       Impact factor: 3.616

4.  Hemagglutinin-neuraminidase glycoprotein as a determinant of pathogenicity in mumps virus hamster encephalitis: analysis of mutants selected with monoclonal antibodies.

Authors:  A Löve; R Rydbeck; K Kristensson; C Orvell; E Norrby
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

5.  Pathways of the early propagation of virulent and avirulent rabies strains from the eye to the brain.

Authors:  P Kucera; M Dolivo; P Coulon; A Flamand
Journal:  J Virol       Date:  1985-07       Impact factor: 5.103

6.  A dot-immunobinding assay for monoclonal and other antibodies.

Authors:  R Hawkes; E Niday; J Gordon
Journal:  Anal Biochem       Date:  1982-01-01       Impact factor: 3.365

7.  Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence.

Authors:  R G Dalziel; P W Lampert; P J Talbot; M J Buchmeier
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

8.  Characterization of saturable binding sites for rabies virus.

Authors:  W H Wunner; K J Reagan; H Koprowski
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

9.  Antigenic and genetic characterization of Sindbis virus monoclonal antibody escape mutants which define a pathogenesis domain on glycoprotein E2.

Authors:  D F Pence; N L Davis; R E Johnston
Journal:  Virology       Date:  1990-03       Impact factor: 3.616

10.  Reduced mouse neurovirulence of poliovirus type 2 Lansing antigenic variants selected with monoclonal antibodies.

Authors:  N La Monica; W J Kupsky; V R Racaniello
Journal:  Virology       Date:  1987-12       Impact factor: 3.616

View more
  8 in total

1.  Characterization of a unique variant of bat rabies virus responsible for newly emerging human cases in North America.

Authors:  K Morimoto; M Patel; S Corisdeo; D C Hooper; Z F Fu; C E Rupprecht; H Koprowski; B Dietzschold
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

Review 2.  The application of reverse genetics technology in the study of rabies virus (RV) pathogenesis and for the development of novel RV vaccines.

Authors:  Matthias J Schnell; Gene S Tan; Bernhard Dietzschold
Journal:  J Neurovirol       Date:  2005-02       Impact factor: 2.643

3.  Vesicular stomatitis virus G protein acquires pH-independent fusion activity during transport in a polarized endometrial cell line.

Authors:  P C Roberts; T Kipperman; R W Compans
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

4.  The rabies virus glycoprotein determines the distribution of different rabies virus strains in the brain.

Authors:  Xiuzhen Yan; Puliyur S Mohankumar; Bernhard Dietzschold; Matthies J Schnell; Zhen F Fu
Journal:  J Neurovirol       Date:  2002-08       Impact factor: 2.643

5.  Concepts in the pathogenesis of rabies.

Authors:  Bernhard Dietzschold; Jianwei Li; Milosz Faber; Matthias Schnell
Journal:  Future Virol       Date:  2008-09       Impact factor: 1.831

6.  Vesicular stomatitis virus glycoprotein is a determinant of pathogenesis in swine, a natural host.

Authors:  Isidoro Martinez; Luis L Rodriguez; Carlos Jimenez; Steven J Pauszek; Gail W Wertz
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

7.  Evidence from the anti-idiotypic network that the acetylcholine receptor is a rabies virus receptor.

Authors:  C A Hanham; F Zhao; G H Tignor
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

8.  Deficient Incorporation of Rabies Virus Glycoprotein into Virions Enhances Virus-Induced Immune Evasion and Viral Pathogenicity.

Authors:  Chunfu Li; Hongliang Zhang; Lina Ji; Xiao Wang; Yongjun Wen; Guangpeng Li; Zhen F Fu; Yang Yang
Journal:  Viruses       Date:  2019-03-04       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.